|
|
|
Monday, November 17th |
|
07.00-16.30 |
Registration desk |
|
08.30-08.45 |
Welcome address and introduction
Nils Wahlgren, Stockholm, and Bo Norrving, Lund
|
|
08.45-10.10 |
Session: Carotid endarterectomy vs angioplasty
Chairs: Philip Bath, Nottingham and Jean-Louis Mas, Paris /Secretary: Konstantinos Kostulas, Stockholm
|
|
| 08.45-09.05 |
The SPACE study: Long-term results of the Stent-protected percutaneous angioplasty of the carotid vs endarterectomy study
Michael Hennerici, Mannheim |
|
| 09.05-09.25 |
The EVA-3S-study: Long-term results ofthe Endarterectomy vs angioplasty in patients with symptomatic severe carotid stenosis study
Jean-Louis Mas, Paris |
|
09.25-09.45 |
The Cavatas study: Long-term results of the Carotid and vertebral artery transluminal angioplasty study
Martin Brown, London |
|
| 09.45-09.55 |
Presentation of draft statement
Konstantinos Kostulas |
|
09.55-10.10 |
Consensus discussion and statement
Chaired Philip Bath, Nottingham
Additional discussants: Ulf Hedin. Stockholm, and Michael Söderman, Stockholm |
|
10.10-10.40 |
Special lecture: Reflections upon the Carotid Artery
Chair: Nils Wahlgren
Speaker: Henry JM Barnett, London Ontario
|
|
| 10.40-11.10 |
Coffee Break |
|
11.10-12.30 |
Session: Antithrombotic therapy
Chair: Didier Leys, Lille, and Anna Czlonkowska, Warsaw /Secretary: Mia von Euler, Stockholm
|
|
| 11.10-11.30 |
After PROFESS: Benefit/risk of antiplatelet treatments, updated review
Hans-Christoph Diener, Essen |
|
| 11.30-11.45 |
After PROFESS: First choice antiplatelet therapy is combined dipyridamole and aspirin
Ale Algra, Utrecht (please note that this is an invited position talk which does not necessarily reflect the speakers personal view) |
|
11.45-12.00 |
After PROFESS: First choice antiplatelet therapy is clopidogrel
Pierre Amarenco, Paris (please note that this is an invited position talk which does not necessarily reflect the speakers personal view) |
|
12.00-12.10 |
Presentation of draft statement
Mia von Euler, Stockholm |
|
12.10-12.30 |
Consensus discussion and statement
Chaired by Didier Leys, Lille |
|
12.30-13.30 |
Lunch and poster exhibition |
|
13.30-14.35 |
Session: TIA - still a clinical definition?
Chair: Peter Ringleb, Heidelberg and Ljiljana Bumbasirevic, Belgrade /Secretary: Ruben Tamazyan, Paris |
|
| 13.30-13.50 |
TIA is a clinical definition
Bo Norrving, Lund |
|
13.50-14.10 |
TIA is a tissue-based definition
Peter Kelly, Dublin |
|
14.10-14.20 |
Presentation of draft statement
Ruben Tamazyan, Paris |
|
14.20-14.35 |
Consensus discussion and statement
Chaired by Peter Ringleb |
|
14.35-15.05 |
Coffee break |
|
15.05-16.15 |
Session: TIA - management in TIA clinics or Stroke Unit care?
Chair: Peter Ringleb, Heidelberg and Vida Demarin, Zagreb/Secretary: Jean-Luc af Geijerstam, Stockholm |
|
| 15.05-15.25 |
TIA is an emergency - use an emergency TIA clinic
Pierre Amarenco, Paris |
|
| 15.25-15.45 |
TIA is an emergency - admit to an acute stroke unit
Gary Ford, Newcastle |
|
| 15.45-15.55 |
Presentation of draft statement
Jean-Luc af Geijerstam, Stockholm |
|
15.55-16.15 |
Consensus discussion and statement
Chaired by Peter Ringleb |
|
16.15-16.25 |
Summary and closing of the first day of the meeting, original programme
Nils Wahlgren, Stockholm |
|
| 16.25-17.00 |
Karolinska Stroke Award Ceremony
Ceremony in the presence of the President of Karolinska Institutet Harriet Wallberg-Henriksson |
|
| |
All participants are welcome to the following satellite session: |
|
17.05-18.05 |
SITS investigators' open session
Open for all meeting participants |
|
| 17.05-17.20 |
SITS - an update on ongoing and planned activities
Nils Wahlgren, Stockholm |
|
| 17.20-17.30 |
HASTA (Hyperacute Stroke Alarm) Study in Stockholm County
Leif Svensson, Stockholm |
|
| 17.30-17.45 |
International Stroke Trial
Veronica Murray. Stockholm |
|
| 17.45-17.55 |
Citicholine in acute stroke - a study concept for SITS
Vladimir Hachinski, London, Ontario |
|
| 17.55-18.10 |
Randomised controlled trial on mechanical retraction of thrombus in acute stroke using the MERCI device
Tommy Andersson, Stockholm |
|
19.30 |
Gala Dinner |
|
|
|
|
Tuesday, November 18th |
|
08.30-08.35 |
Introduction to day 2 |
|
08.35-10.25 |
Session: Should the time window for intravenous thrombolysis be extended?
Chair: Markku Kaste, Helsinki, and Robert Mikulik, Brno /Secretary: Nikolaos Kostulas, Stockholm
|
|
08.35-08.55 |
ECASS 3 - main results
Kennedy R Lees, Glasgow |
|
| 08.55-09.10 |
Outcomes for patients treated between 3 and 4.5 hours in the SITS register
Nils Wahlgren, Stockholm |
|
| 09.10-09.25 |
Updated pooled analysis of randomised trials of intravenous alteplase in acute ischaemic stroke
Danilo Toni, Rome |
|
09.25-09.40 |
Updated Cochrane review of intravenous thrombolysis for acute ischaemic stroke
Peter Sandercock, Edinburgh |
|
09.40-09.50 |
Extend the time window - yes
Antoni Davalos, Badalona (please note that this is an invited position talk which does not necessarily reflect the speakers personal view) |
|
| 09.50-10.00 |
Extend the time window - no
Peter Sandercock, Edinburgh (please note that this is an invited position talk which does not necessarily reflect the speakers personal view) |
|
| 10.00-10.10 |
Presentation of draft statement
Nikolaos Kostulas, Stockholm |
|
10.10-10.25 |
Consensus discussion and statement
Chaired by Markku Kaste, Helsinki |
|
10.25-10.55 |
Coffee break |
|
10.55-11.25 |
Special lecture: Is the mismatch concept valid?
Chair: Bo Norrving, Lund
Speaker: Jan Sobesky, Cologne |
|
11.25-12.30 |
Session: Management of hyperglycemia and diabetes mellitus in stroke
Chair: Keith Muir, Glasgow/ Secretary: Christina Sjöstrand, Stockholm |
|
| 11.25-11.45 |
Update on treatment of diabetes mellitus after stroke in the perspective of the ACCORD and ADVANCE studies
Per Wester, Umeå |
|
| 11.45-12.05 |
Update on management of hyperglycemia in the acute phase of stroke
Natan Bornstein, Tel Aviv |
|
| 12.05-12.15 |
Presentation of draft statement
Christina Sjöstrand, Stockholm |
|
| 12.15-12.30 |
Consensus discussion and statement
Chaired by Keith Muir, Glasgow |
|
12.30-13.25 |
Lunch and poster exhibition |
|
13.25-13.45 |
Special lecture: Is vascular cognitive impairment a useful concept?
Chair: Nils Wahlgren, Stockholm
Speaker: Vladimir Hachinski, London, Ontario |
|
13.45-14.45 |
Session: Blood pressure management in the acute phase of stroke
Chair: Jacques De Keyser, Brussels and László Csiba, Debrecen/ Secretary: Magnus Thorén, Stockholm |
|
13.45-14.05 |
Treatment with telmisartan, a blood pressure lowering agent, within the first 3 days of acute ischaemic stroke. Results from PROFESS
Philip Bath, Nottingham |
|
| 14.05-14.20 |
Relation of blood pressure with symptomatic intracerebral haemorrhage, mortality and independence at three months, based on data from 10,581 patients in SITS
Niaz Ahmed, Stockholm |
|
| 14.20-14.30 |
Presentation of draft statement
Magnus Thorén, Stockholm |
|
14.30-14.45 |
Consensus discussion and statement
Jacques De Keyser, Brussels |
|
14.45-15.15 |
Coffee break |
|
15.15-17.00 |
Session: Management of intracranial aneurysms and subarachnoid haemorrhage
Chair Thorsten Steiner, Heidelberg, Co-Chair Mikael Svensson, Stockholm /Secretaries: Tommy Andersson. Stockholm and Staffan Holmin, Stockholm |
|
15.15-15.35 |
Surgical treatment
Andreas Unterberg, Heidelberg
|
|
| 15.35-15.55 |
Neuroradiological diagnosis and intravascular management
René Chapot, Essen
|
|
15.55-16.15 |
Medical management
Gabriel Rinkel, Utrecht |
|
| 16.15-16.35 |
Epidemilogical aspects
Seppo Juvela, Helsinki |
|
| 16.35-16.45 |
Presentation of draft consensus statement
Tommy Andersson, Stockholm |
|
| 16.45-17.00 |
Consensus discussion and statement
Chaired by Thorsten Steiner, Heidelberg |
|
17.00-17.15 |
Summary and closing of the meeting
Nils Wahlgren, Stockholm, and Bo Norrving. Lund |
|
